International Journal of Pharmaceutics

Numerical simulation of milling processes as an aid to process design
pp. 1-11(11)
Authors: Annapragada A.; Adjei A.

Comparison of a spray-dried -lactose monohydrate with a fully hydrated roller-dried -lactose
pp. 13-21(9)
Authors: Cal S.; Rodriguez-Puente B.; Souto C.; Concheiro A.; Gomez-Amoza J.L.; Martinez-Pacheco R.

Biodegradable polymer matrices for the sustained exogenous delivery of a biologically active c-myc hammerhead ribozyme
pp. 23-29(7)
Authors: Hudson A.J.; Lewis K.J.; Rao M.V.; Akhtar S.

Macromolecular prodrugs. VII. Polymer-dopamine conjugates
pp. 31-36(6)
Authors: Kalcic I.; Zorc B.; Butula I.

Effect of polycarbophil concentration on diclofenac sodium bioavailability from suppositories in beagle dogs
pp. 37-41(5)
Authors: Hosny E.A.; Niazy E.M.; El-Dardari M.M.

Evaluation of stereoselective dissolution of verapamil hydrochloride from matrix tablets press-coated with chiral excipients
pp. 43-51(9)
Authors: Maggi L.; Massolini G.; De Lorenzi E.; Conte U.; Caccialanza G.

Absorption of glucagon-like peptide-1 can be protracted by zinc or protamine
pp. 53-59(7)
Authors: Pridal L.; Agerbaek H.; Christensen L.N.; Thomsen K.; Kirk O.

Prodrugs of peptides obtained by derivatization of the C-terminal peptide bond in order to effect protection against degradation by carboxypeptidases
pp. 61-69(9)
Authors: Friis G.J.; Bak A.; Due Larsen B.; Frokjaer S.

Investigation on bonding and disintegration properties of pharmaceutical materials
pp. 71-79(9)
Authors: Ferrari F.; Bertoni M.; Bonferoni M.C.; Rossi S.; Caramella C.; Nystrom C.

Preformulation activities of intranasal dosage forms of temazepam
pp. 81-88(8)
Authors: Muggetti L.; Zurlo M.; Martini A.; Civaroli P.; De Ponti R.

The preparation and evaluation of salbutamol sulphate containing poly(lactic acid-co-glycolic acid) microspheres with factorial design-based studies
pp. 89-100(12)
Authors: Celebi N.; Erden N.; Turkyilmaz A.

Fractal and reactive dimension of a diclofenac salt: effect of the experimental conditions
pp. 101-106(6)
Authors: Fernandez-Hervas M.J.; Holgado M.A.; Rabasco A.M.; Fazio G.; Fini A.

In vitro evaluation of sustained-release matrix tablets prepared with new modified polymeric carbohydrates
pp. 107-115(9)
Authors: Velasco M.V.; Munoz A.; Jimenez-Castellanos M.R.; Castellano I.; Gni I.; Gurruchaga M.

Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery
pp. 117-139(23)
Authors: Rouge N.; Buri P.; Doelker E.

Water mobility in amorphous lactose below and close to the glass transition temperature
pp. 141-146(6)
Authors: Buckton G.; Darcy P.

Comparative bioavailability of L-683,453, a 5-reductase inhibitor, from a self-emulsifying drug delivery system in Beagle dogs
pp. 147-154(8)
Authors: Matuszewska B.; Hettrick L.; Bondi J.V.; Storey D.E.

Novel peroral dosage forms with protease inhibitory activities. I. Design of capsules with fast gel-forming and fast drug-releasing properties
pp. 155-163(9)
Authors: Akiyama Y.; Lueszen H.L.; de Boer A.G.; Verhoef J.C.; Junginger H.E.

Inclusion complexation of amide-typed local anaesthetics with -cyclodextrin and its derivatives. II. Evaluation of affinity constants and in vitro transfer rate constants
pp. 165-174(10)
Authors: Dollo G.; Le Corre P.; Chevanne F.; Le Verge R.

Influence of agglomeration of cohesive particles on the dissolution behaviour of furosemide powder
pp. 175-179(5)
Author: de Villiers M.M.